Medpace Holdings

MEDPsupplier

Medpace is a differentiated full-service CRO focused exclusively on biotech clients (not Big Pharma), with a scientific-first model and 40+ year average clinician tenure driving industry-best quality.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($2.30B)

Data statis (memuat keuangan langsung…)

Net Revenue (Services) (100%)

Komposisi segmen dan pelanggan utama

Detail produk

Full-Service CRO85%

End-to-end clinical trial management for biotech clients — Phase I-IV, regulatory, data management, biometrics.

Regulatory Consulting15%

FDA/EMA regulatory strategy, IND/NDA writing, and submission preparation.

Hubungan Rantai Pasok

Pelanggan Utama

Eli Lilly and Company

Phase II/III clinical trial management

Dampak: moderate

Moderna, Inc.

mRNA vaccine clinical services

Dampak: moderate

Konteks makro dan pasar

헬스케어Berita sektor

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Katalis mendatang

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok Medpace Holdings.

Info Perusahaan

Kantor Pusat

Cincinnati, Ohio, USA

Didirikan

1992

Karyawan

5,800

Situs Web

medpace.com

Gambaran umum sektor — 헬스케어

Berita sektor